GMP Cytokines Market is expected to reach US$ 158.13 Mn by 2027 | Miltenyi Biotec; Sino Biological Inc.; ABCAM; PeproTech Inc.; Akron Biotech; CellGenix GmbH; BIO-TECHNE CORPORATION; CREATIVE BIOARRAY; Proteintech Group, Inc.; and REPROCELL Inc

According to our new research study on “GMP Cytokines Market Forecast to 2027 – COVID-19 Impact and Analysis – by Type, and Application,” the market is expected to reach US$ 158.13 million in 2027 from US$ 84.72 million in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027. The report highlights trends prevailing in the global GMP cytokines market and factors governing the market growth.

Get a Sample Copy of the Report@ https://www.theinsightpartners.com/sample/TIPRE00008212/?openpr-10225

Based on type, the growth factors segment held the largest share of the market in 2019; whereas, the TNF segment is expected to grow at the fastest CAGR during the forecast period. TNF-α is cytotoxic to a wide range of tumor cells, and is a vital factor in stimulating immune response against bacterial infections. Increasing prevalence of cancer and infectious diseases is likely to propel the growth of the segment. Additionally, an extensive research study on TNF is likely to favor the growth of the segment during the forecast period. For instance, ‘Nonconventional induction strategies for production of recombinant human tumor necrosis factor-alpha in Escherichia coli’ was published in 2018.

The growth of the GMP cytokines market is mainly attributed to the increase in acceptance of cytokines cancer and autoimmune therapies and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.

Miltenyi Biotec; Sino Biological Inc.; ABCAM; PeproTech Inc.; Akron Biotech; CellGenix GmbH; BIO-TECHNE CORPORATION; CREATIVE BIOARRAY; Proteintech Group, Inc.; and REPROCELL Inc. are among the leading companies operating in the GMP cytokines market.

Market Insights

Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies

Cytokines play significant role in the regulation of innate and adaptive immunity, which enable cells of the immune system to communicate over short distances. The cytokine therapy to activate the immune system of cancer patients has been an essential parameter in the treatment of cancer and continues to be a prime contributor to present clinical cancer research. Interferon-alpha is one of the approved cytokines for the adjuvant treatment of refractory malignancies. Several research activities have proved the ability of cytokines to limit tumor cell growth by a direct anti-proliferative or pro-apoptotic activity. Moreover, some cytokines inhibit the tumor growth indirectly by stimulating the cytotoxic activity of immune cells against tumor cells. This effectiveness of cytokines therapies over cancer coupled with increasing prevalence of the disease is likely to drive the market by 2027. According to the World Health Organization, in 2019, approximately 9.6 million deaths across the globe were due to cancer.

Additionally, increasing number of investments and collaborations to develop cytokine therapies over cancer and autoimmune diseases are also expected to accelerate the market growth. For instance, in September 2020, Synthekine Inc. raised US$ 82.0 million through rounds of series funding. The company is engaged in the development of cytokine therapeutics for the treatment of cancer and autoimmune disorders.

The report segments global GMP cytokines market as follows:

By Type

TNF
Interleukin
Growth Factor
Others

By Application

Cell and Gene Therapy
Tissue-Engineered Products
Others

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of Middle East and Africa
South and Central America (SCAM)
Brazil
Argentina
Rest of South and Central America

Purchase a Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00008212/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense

This release was published on openPR.